Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 24, 2023

SELL
$31.15 - $33.39 $3,115 - $3,339
-100 Reduced 0.48%
20,800 $691,000
Q3 2022

Oct 19, 2022

SELL
$30.9 - $33.55 $6,180 - $6,709
-200 Reduced 0.95%
20,900 $659,000
Q2 2022

Jul 20, 2022

SELL
$23.75 - $31.69 $2,375 - $3,169
-100 Reduced 0.47%
21,100 $686,000
Q1 2022

Apr 22, 2022

BUY
$19.97 - $26.94 $3,994 - $5,388
200 Added 0.95%
21,200 $586,000
Q4 2021

Jan 14, 2022

BUY
$17.46 - $21.61 $1,746 - $2,161
100 Added 0.48%
21,000 $428,000
Q3 2021

Oct 12, 2021

BUY
$17.35 - $22.5 $24,290 - $31,500
1,400 Added 7.18%
20,900 $402,000
Q2 2021

Jul 16, 2021

SELL
$18.01 - $28.32 $1,801 - $2,832
-100 Reduced 0.51%
19,500 $433,000
Q1 2021

Apr 14, 2021

SELL
$19.76 - $29.89 $3,952 - $5,978
-200 Reduced 1.01%
19,600 $515,000
Q3 2020

Oct 19, 2020

BUY
$13.54 - $26.41 $110,892 - $216,297
8,190 Added 70.54%
19,800 $336,000
Q2 2020

Jul 13, 2020

SELL
$7.84 - $23.29 $1,568 - $4,658
-200 Reduced 1.69%
11,610 $270,000
Q1 2020

Apr 13, 2020

SELL
$5.57 - $11.5 $15,818 - $32,660
-2,840 Reduced 19.39%
11,810 $99,000
Q4 2019

Jan 17, 2020

SELL
$7.9 - $10.14 $9,085 - $11,661
-1,150 Reduced 7.28%
14,650 $143,000
Q3 2019

Oct 24, 2019

SELL
$9.17 - $12.01 $917 - $1,201
-100 Reduced 0.63%
15,800 $150,000
Q1 2019

Apr 15, 2019

SELL
$15.51 - $17.61 $589 - $669
-38 Reduced 0.24%
15,900 $280,000
Q4 2018

Jan 14, 2019

SELL
$14.52 - $19.72 $40,104 - $54,466
-2,762 Reduced 14.77%
15,938 $277,000
Q3 2018

Oct 16, 2018

SELL
$14.85 - $16.35 $4,455 - $4,905
-300 Reduced 1.58%
18,700 $279,000
Q2 2018

Jul 18, 2018

BUY
$13.8 - $16.8 $2,760 - $3,360
200 Added 1.06%
19,000 $302,000
Q1 2018

Apr 18, 2018

BUY
$13.8 - $16.2 $8,280 - $9,720
600 Added 3.3%
18,800 $267,000
Q4 2017

Jan 16, 2018

BUY
$13.55 - $15.8 $14,905 - $17,380
1,100 Added 6.43%
18,200 $255,000
Q3 2017

Oct 16, 2017

BUY
$13.45 - $14.35 $229,995 - $245,385
17,100
17,100 $245,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Louisiana State Employees Retirement System Portfolio

Follow Louisiana State Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Louisiana State Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Louisiana State Employees Retirement System with notifications on news.